JUL 8, 2026 · JOURNAL ARTICLE
Influenza Vaccination as Cardiovascular Prevention in Adults with Heart Disease
Journal of Clinical Medicine
Multiple randomized trials and meta-analyses support reductions in major adverse cardiovascular events, cardiovascular mortality, and all-cause mortality in secondary-prevention populations, with particularly persuasive evidence after myocardial infarction, though the source does not report specific effect sizes or confidence intervals.